Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
基本信息
- 批准号:10640938
- 负责人:
- 金额:$ 56.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcupuncture TherapyAcuteAddressAdverse eventAffectAnalgesicsBostonCOVID-19Cardiac Surgery proceduresCardiovascular AgentsCardiovascular DiseasesCaringCategoriesCessation of lifeChronicChronic Obstructive Pulmonary DiseaseChronic low back painClinicalClinical TrialsClinical assessmentsCommunitiesDataDecision MakingDeliriumDementiaDiabetes MellitusDrug PrescriptionsEffectivenessElderlyElectronic Health RecordFundingGoalsHealth Care CostsHealth Services ResearchHealth StatusHealth systemHealthcare SystemsHeart failureHip FracturesHomeHospitalizationHospitalsInstitutionalizationIntensive Care UnitsInvestigationLinkMassachusettsMeasurementMeasuresMedicareMethodsMissionModelingNational Institute on AgingOperative Surgical ProceduresOsteoporosisOutcomes ResearchParticipantPatient SelectionPatient-Centered CarePatientsPeripheral arterial diseasePersonsPharmaceutical PreparationsPharmacoepidemiologyPharmacotherapyPneumoniaPopulationPragmatic clinical trialProviderPublic HealthQualifyingRandomized, Controlled TrialsResearchResearch PersonnelResourcesSamplingSkilled Nursing FacilitiesSystemTestingTimeUnited States National Institutes of HealthVariantVentilatorWorkacute careclinical careclinical practiceclinically actionablecomorbiditycomparative effectiveness studycostcritical limb Ischemiadisabilityevidence baseexperiencefrailtyhealth managementhospital careimprovedindexinginnovationmedication safetypersonalized carepoor health outcomepopulation healthpragmatic trialpredictive modelingprogramsrevascularization surgeryrisk predictionrisk stratificationroutine caresafety studytreatment as usualtreatment effectvenous thromboembolism
项目摘要
PROJECT SUMMARY/ABSTRACT
Older adults with frailty are more likely to experience poor health outcomes after acute illnesses, drug-related
adverse events, and surgeries. Health care costs for frail patients double due to acute hospital care, post-acute
care, and treatments for preventable conditions. Despite clinical and societal consequences of frailty, frailty is
rarely assessed in clinical practice and little evidence exists on how to integrate frailty to inform clinical care and
population health management. The critical step to generate this evidence is to measure frailty on a large scale
with high accuracy and efficiency. To address this need, the investigator team recently developed and validated
a claims-based frailty index (CFI), which enables measurement of frailty from Medicare data for large populations
when in-person assessment is not feasible. The objective of this application is to generate evidence needed for
frailty-guided clinical care and population health management by applying CFI to claims data-based studies of
drug therapy; pragmatic clinical trials of procedural therapy; and electronic health records (EHR)-Medicare linked
data of a health care system. The central hypothesis is that frailty information will improve care of older adults
by uncovering meaningful variations in the treatment benefit-harm profile, costs, and resource needs. To test
this hypothesis, the investigator team with extensive expertise in frailty, pharmacoepidemiologic methods, and
health services research will accomplish the following specific aims in the next 5 years: 1) determine how frailty
changes the benefits and harms of 10 prescription drugs for chronic conditions in older adults by applying CFI
to the 2014-2022 5% Medicare random sample; 2) determine how frailty changes the benefits and harms of
procedural therapies in older adults by applying CFI to Medicare data linked to 2 ongoing pragmatic clinical trials
of endovascular vs surgical revascularization therapy for peripheral arterial disease and acupuncture vs usual
care for chronic low back pain; and 3) determine whether implementing CFI to EHR-Medicare linked data can
predict high-cost and high-need patients in a large health care system in Boston, Massachusetts. The innovative
applications of CFI are readily scalable to claims-based comparative effectiveness and safety studies, clinical
trials, and EHR in health care systems. The impact of this research is significant because the clinically actionable
evidence generated from this research can enable optimal choice of drug and procedural therapy and a health
system-wide risk stratification based on frailty. Ultimately, these results will accelerate integration of frailty in
routine care and facilitate frailty-guided clinical care and population health management.
项目概要/摘要
身体虚弱的老年人在患上与药物相关的急性疾病后,更容易出现健康状况不佳的情况
不良事件和手术。由于急性住院护理、急性后护理,体弱患者的医疗费用增加了一倍
可预防疾病的护理和治疗。尽管虚弱会产生临床和社会后果,但虚弱是
很少在临床实践中进行评估,也很少有证据表明如何将虚弱纳入临床护理和
人口健康管理。产生这一证据的关键步骤是大规模测量脆弱性
具有高精度和高效率。为了满足这一需求,研究团队最近开发并验证了
基于索赔的虚弱指数 (CFI),可以根据大量人群的医疗保险数据来衡量虚弱程度
当亲自评估不可行时。该应用程序的目的是生成所需的证据
通过将 CFI 应用于基于索赔数据的研究,以虚弱为指导的临床护理和人口健康管理
药物治疗;程序性治疗的实用临床试验;和电子健康记录 (EHR)-医疗保险相关
医疗保健系统的数据。中心假设是衰弱信息将改善老年人的护理
通过揭示治疗利害关系、成本和资源需求方面的有意义的变化。测试
对于这一假设,研究团队在虚弱、药物流行病学方法和方法方面拥有丰富的专业知识
卫生服务研究将在未来 5 年内实现以下具体目标: 1) 确定脆弱性如何
通过应用 CFI 改变 10 种处方药治疗老年人慢性病的益处和危害
2014-2022 年 5% 医疗保险随机样本; 2)确定虚弱如何改变其益处和危害
通过将 CFI 应用于与 2 项正在进行的实用临床试验相关的医疗保险数据,对老年人进行程序性治疗
外周动脉疾病的血管内血运重建治疗与手术血运重建治疗以及针灸与常规治疗的比较
护理慢性腰痛; 3) 确定对 EHR-Medicare 链接数据实施 CFI 是否可以
预测马萨诸塞州波士顿大型医疗保健系统中的高费用和高需求患者。创新的
CFI 的应用很容易扩展到基于声明的比较有效性和安全性研究、临床
试验以及医疗保健系统中的 EHR。这项研究的影响是重大的,因为临床上可行
这项研究产生的证据可以实现药物和程序治疗的最佳选择以及健康
基于脆弱性的全系统风险分层。最终,这些结果将加速脆弱性的整合
常规护理并促进虚弱指导的临床护理和人口健康管理。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Feasibility of implementing a telephone-based frailty assessment.
- DOI:10.1111/jgs.18031
- 发表时间:2022-12
- 期刊:
- 影响因子:6.3
- 作者:Sison, Stephanie Denise M.;Newmeyer, Natalie;Arias, Karla Tejada;Schoenburg, Racheli;Valencia, Carolina Fonseca;Cheslock, Megan;Raman, Vaishnavi;Driver, Jane A.;Kim, Dae Hyun
- 通讯作者:Kim, Dae Hyun
Osteoporosis Medications Prevent Subsequent Fracture in Frail Older Adults.
- DOI:10.1002/jbmr.4693
- 发表时间:2022-11
- 期刊:
- 影响因子:6.2
- 作者:Chattaris, Tanchanok;Oh, Gahee;Gouskova, Natalia A.;Kim, Dae Hyun;Kiel, Douglas P.;Berry, Sarah D.
- 通讯作者:Berry, Sarah D.
Correction to: Change in a Claims-Based Frailty Index, Mortality, and Health Care Costs in Medicare Beneficiaries.
更正:医疗保险受益人基于索赔的衰弱指数、死亡率和医疗保健费用的变化。
- DOI:10.1093/gerona/glad190
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
A crosswalk of commonly used frailty scales.
常用衰弱量表的人行横道。
- DOI:10.1111/jgs.18453
- 发表时间:2023
- 期刊:
- 影响因子:6.3
- 作者:Sison,StephanieDeniseM;Shi,SandraM;Kim,KyungMoo;Steinberg,Nessa;Jeong,Sohyun;McCarthy,EllenP;Kim,DaeHyun
- 通讯作者:Kim,DaeHyun
Utilization of transitional care management service among Medicare beneficiaries at high risk of readmission.
在再入院高风险的医疗保险受益人中利用过渡护理管理服务。
- DOI:10.1111/jgs.18878
- 发表时间:2024
- 期刊:
- 影响因子:6.3
- 作者:Park,ChanMi;McCarthy,EllenP;Shi,Sandra;Olivieri-Mui,Brianne;Jang,Jieun;Kim,DaeHyun
- 通讯作者:Kim,DaeHyun
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dae Hyun Kim其他文献
Dae Hyun Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dae Hyun Kim', 18)}}的其他基金
Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes
职业生涯中期指导奖,表彰以患者为导向的虚弱和健康结果研究
- 批准号:
10448534 - 财政年份:2022
- 资助金额:
$ 56.33万 - 项目类别:
Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes
职业生涯中期指导奖,表彰以患者为导向的虚弱和健康结果研究
- 批准号:
10651807 - 财政年份:2022
- 资助金额:
$ 56.33万 - 项目类别:
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
- 批准号:
10297953 - 财政年份:2021
- 资助金额:
$ 56.33万 - 项目类别:
Prospective Monitoring of Newly Approved Cardiovascular Drugs in Older Adults with Frailty
新批准的心血管药物对虚弱老年人的前瞻性监测
- 批准号:
10338082 - 财政年份:2019
- 资助金额:
$ 56.33万 - 项目类别:
Epidemiology and Risk of Antipsychotic Use in Hospitalized Elderly with Delirium
患有谵妄的住院老年人的流行病学和使用抗精神病药物的风险
- 批准号:
9980746 - 财政年份:2018
- 资助金额:
$ 56.33万 - 项目类别:
Development and Validation of a Frailty Index Using Claims Data for Pharmacoepidemiologic Studies in Older Adults
使用老年人药物流行病学研究的索赔数据开发和验证虚弱指数
- 批准号:
8966383 - 财政年份:2015
- 资助金额:
$ 56.33万 - 项目类别:
相似国自然基金
基于Nrf2/ARE通路探讨针灸抗氧应激改善卵巢功能的miRNA作用机制
- 批准号:81774408
- 批准年份:2017
- 资助金额:50.0 万元
- 项目类别:面上项目
针灸对染色质重塑介导的克罗恩病自噬的调节机制研究
- 批准号:81674069
- 批准年份:2016
- 资助金额:63.0 万元
- 项目类别:面上项目
针灸阻抑克罗恩病肠纤维化上皮间质转化的分子调控机制
- 批准号:81473757
- 批准年份:2014
- 资助金额:74.0 万元
- 项目类别:面上项目
艾灸调节溃疡性结肠炎肠道菌群多样性及艾灸血清对其LPS信号通路的作用机制研究
- 批准号:81473758
- 批准年份:2014
- 资助金额:74.0 万元
- 项目类别:面上项目
基于针灸抗炎作用防治阿尔茨海默病星形胶质细胞介导的β-淀粉样蛋白代谢机制研究
- 批准号:81473786
- 批准年份:2014
- 资助金额:72.0 万元
- 项目类别:面上项目
相似海外基金
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 56.33万 - 项目类别:
Planning a phase I study of minor salivary gland derived autologous MSCs for prevention of long-term radiation induced xerostomia
计划对小唾液腺来源的自体 MSC 进行 I 期研究,以预防长期辐射引起的口干症
- 批准号:
10720234 - 财政年份:2023
- 资助金额:
$ 56.33万 - 项目类别:
A nonpharmacological therapeutic intervention of TBI-induced facial allodynia/hyperalgesias in a rodent model
啮齿动物模型中 TBI 引起的面部异常性疼痛/痛觉过敏的非药物治疗干预
- 批准号:
10611481 - 财政年份:2022
- 资助金额:
$ 56.33万 - 项目类别:
Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making
应用基于索赔的衰弱指数为衰弱指导决策提供证据
- 批准号:
10297953 - 财政年份:2021
- 资助金额:
$ 56.33万 - 项目类别:
The glymphatic system at the crossroad of integrative health approaches inchronic pain
处于综合健康十字路口的类淋巴系统接近慢性疼痛
- 批准号:
10626911 - 财政年份:2021
- 资助金额:
$ 56.33万 - 项目类别: